Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CTMX

CytomX Therapeutics, Inc.

CIK 0001501989 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$3.28
↓ 0.01 (-0.30%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals, Technicals

Key stats

Market Cap
$714.71M
P/E Ratio
-8.97
EPS
Not covered
Dividend Yield
Not covered
52W Position
22%
Beta
1.68

Valuation multiples

Fwd P/E
14.20
PEG
-1.80
P/B
2.37
P/S
39.05
EV/Revenue
38.11
ROE
-26.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 22%
$1.90$8.21

Latest Financials

2025-12-31 FY
Revenue
$76.20M
Net Income
-$17.37M
Total Assets
$151.57M
Free Cash Flow
-$75.81M

Recent news